Adnan Munkarah Selected Research

Adnan Munkarah Research Topics

Disease

31	Neoplasms (Cancer) 10/2023 - 01/2004
16	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2002
5	Carcinoma (Carcinomatosis) 04/2016 - 04/2011
3	Endometrial Neoplasms (Endometrial Cancer) 01/2019 - 01/2011
3	Ovarian Epithelial Carcinoma 04/2016 - 10/2009
3	Endometrioid Carcinoma 07/2012 - 04/2011
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2010 - 06/2004
2	Neoplasm Metastasis (Metastasis) 01/2012 - 06/2004
2	Adenocarcinoma 10/2011 - 08/2011
2	Leiomyoma (Uterine Fibroids) 12/2010 - 01/2004
2	Carcinosarcoma 07/2010 - 08/2005
1	Obesity 07/2015
1	Uterine Neoplasms (Uterine Cancer) 07/2015
1	Polymyositis 01/2012
1	Breast Neoplasms (Breast Cancer) 08/2011
1	Uterine Hemorrhage (Uterine Bleeding) 08/2010
1	Serous Cystadenoma 01/2010
1	Neutropenia 06/2008
1	Disease Progression 06/2008
1	Fatigue 06/2008
1	Nijmegen Breakage Syndrome 01/2006
1	Female Genital Diseases 01/2006
1	Hypoxia (Hypoxemia) 02/2005
1	Lymphatic Metastasis 06/2004
1	Smooth Muscle Tumor 01/2004

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2005
5	PlatinumIBA 05/2016 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 03/2015 - 02/2007
3	AntigensIBA 01/2012 - 01/2006
3	Topotecan (Hycamtin)FDA LinkGeneric 06/2008 - 01/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2023 - 03/2023
2	CytokinesIBA 10/2023 - 03/2023
2	Antineoplastic Agents (Antineoplastics)IBA 03/2023 - 11/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2006
2	Messenger RNA (mRNA)IBA 11/2017 - 04/2016
1	atezolizumabIBA 01/2022
1	VaccinesIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	FurinIBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 11/2021
1	TransferasesIBA 11/2021
1	dihydrolipoamideIBA 11/2021
1	Complement Receptors (Complement Receptor)IBA 01/2020
1	MucinsIBA 01/2020
1	ElementsIBA 01/2020
1	A-factor (Streptomyces)IBA 01/2019
1	NAD (NADH)IBA 11/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2017
1	3' Untranslated Regions (3' UTR)IBA 11/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 04/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2016
1	ceric oxide (cerium dioxide)IBA 03/2016
1	Protein Isoforms (Isoforms)IBA 03/2016
1	ChemokinesIBA 11/2015
1	Lysine (L-Lysine)FDA Link 11/2015
1	DNA (Deoxyribonucleic Acid)IBA 11/2015
1	MethyltransferasesIBA 11/2015
1	Histones (Histone)IBA 11/2015
1	Metformin (Glucophage)FDA LinkGeneric 01/2012
1	AutoantibodiesIBA 01/2012
1	Platelet-Derived Growth FactorIBA 08/2011
1	ErbB Receptors (EGF Receptor)IBA 08/2011
1	VimentinIBA 08/2011
1	Cadherins (E-Cadherin)IBA 08/2011
1	ParaffinIBA 01/2011
1	taxaneIBA 11/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2010
1	Follicle Stimulating Hormone (Follitropin)FDA Link 08/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2010
1	Phosphotransferases (Kinase)IBA 01/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2010
1	Bortezomib (Velcade)FDA Link 10/2009
1	Protein Kinases (Protein Kinase)IBA 10/2009
1	UbiquitinIBA 10/2009
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2009
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2006
1	Casein Kinase II (Casein Kinase 2)IBA 01/2006
1	ribosomal protein L4IBA 01/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2005
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2005
1	LycopeneIBA 01/2004

Therapy/Procedure

9	Therapeutics 03/2023 - 06/2004
7	Radiotherapy 02/2014 - 06/2004
6	Drug Therapy (Chemotherapy) 05/2016 - 06/2004
4	Hysterectomy 07/2015 - 04/2011
3	Immunotherapy 11/2021 - 11/2015
2	Brachytherapy 03/2015 - 04/2011
1	Adjuvant Chemotherapy 05/2015
1	Length of Stay 12/2010
1	Maintenance Chemotherapy 11/2010
1	Salpingo-oophorectomy 10/2010
1	Lymph Node Excision (Lymph Node Dissection) 07/2010